BCL3 and neoplasm: BCL3 may serve as a primary marker to guide treatments, as it assists in customizing patient care during OCC management. Many medical studies demonstrate that BCL3 serves as a vital oncogenic factor affecting tumour progression and immune system suppression in various malignancies, such as OSCC [14].